Von Hippel-Lindau Market

Key Players

• Eli Lilly and Company
• Bedford Laboratories
• DNAtrix, Inc.
• Astellas US Holding, Inc.
• Advantagene, Inc
• Burzynski Research Institute, Inc.
• Cellectar Biosciences, Inc.
• Direct Therapeutics, Inc.